期刊文献+

白三烯生物合成通路遗传变异与缺血性脑卒中相关性研究进展 被引量:1

Genetic variation in the leukotriene biosynthesis pathway and its association with ischemic stroke
下载PDF
导出
摘要 缺血性脑卒中(Is)是一种复杂的多因素、多基因遗传变异性疾病,遗传因素在其发病机制中起重要作用。动脉粥样硬化作为一种慢性炎症性疾病,是缺血性脑卒中的主要病因。白三(LT)烯生物合成通路参与炎症反应,引发血管炎症和动脉粥样硬化的形成。本文对白三烯生物合成通路遗传变异影响、缺血性脑卒中发病的分子机制及两者的相关性研究做一综述。 Objective Ischemic stroke is a complex multifactorial and polygenic genetic heterogeneity disease. Genetic factors play vital roles in its pathogenesis. Atheroselerosis, a chronic inflammation disorder, is the main cause of isehemic stroke. Leukotriene biosynthesis pathway is involved in the inflammatory response, initiating the vascular inflammation and the formation of atherosclerosis. This article reviews the molecule mechanism of genetic variation of the leukotriene biosynthesis pathway affecting ischemic stroke and the association study between them.
出处 《中国急救医学》 CAS CSCD 北大核心 2011年第12期1126-1129,共4页 Chinese Journal of Critical Care Medicine
基金 江苏省卫生厅科研项目(No.H201005)
关键词 缺血性脑卒中(IS) 白三烯(LT) 遗传变异 相关性研究 Ischemic stroke(IS) Leukotriene(LT) Genetic variation Association study
  • 相关文献

参考文献30

  • 1Yamada Y, Ichihara S, Nishida T. Proinflammatorygene polymorphisms and ischemic stroke[J]. Curr Pharm Des, 2008, 14 (33) : 3590 - 3600. 被引量:1
  • 2Liu J, Sun K, Bai Y, et al. Association of three - gene interaction among MTHFR, ALOX5AP and NOTCH3 with thrombotic stroke: a muhicenter case - control study [ J ]. Hum Genet, 2009, 125 (5 - 6 ) : 649 - 656. 被引量:1
  • 3Bain G, King CD, Rewolinski M, et al. Pharmacodynamics and pharmacokinetics of AM103, a novel inhibitor of 5 - lipoxygenase - activating protein (FLAP)[J]. Clin Pharmacol Ther, 2010, 87 (4) : 437 -444. 被引量:1
  • 4Helgadottir A, Manolescu A, Thorleifsson G, et al The gene encoding 5 - lipoxygenase activating protein confers risk of myocardial infarction and stroke[ J ]. Nat Genet, 2004, 36 (3) : 233 - 239. 被引量:1
  • 5Helgadottir A, Manolescu A, Helgason A, et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity - specific risk of myocardial infarction [ J ] Nat Genet, 2006, 38 ( 1 ) : 68 - 74. 被引量:1
  • 6Evans JF,Ferguson AD, Mosley RT, et al. What' s all the FLAP about : 5 - lipoxygenase - activating protein inhibitors for inflammatory diseases[J]. Trends Pharmacol Sci, 2008, 29(2): 72 -78. 被引量:1
  • 7Spanbroek, R, Grabner R, Lotzer K, et al. Expanding expression of the 5 - lipoxygenase pathway within the arterial wall during human atherogenesis[ J ]. Proc Natl Acad Sci USA, 2003, 100(3 ) : 1238 - 1243. 被引量:1
  • 8Riccioni G,Back M, Capra V. Leukotrienes and atherosclerosis[ J]. Curt Drug Targets, 2010, 11(7) : g82 -887. 被引量:1
  • 9Dwyer JH, Allayee H, Dwyer KM, et al. Arachidonate 5 - Lipoxygenase Promoter Genotype, Dietary Arachidonie Acid, and Atherosclerosis[J]. N Engl J Med, 2004, 350(1): 29-37. 被引量:1
  • 10Mehrabian M, Allayee H, Woug J, et al. Identification of 5 - hpoxygenase as a major gene contributing to atherosclerosis susceptibility in mice[J]. Circ Res, 2002, 91(2) : 120 - 126. 被引量:1

二级参考文献2

共引文献11

同被引文献39

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部